Tag Archives: metastatic
New Prostate Cancer Drug Approved by FDA
Good news for patients with metastatic prostate cancer. The FDA (US Food and Drug Administration) has approved Johnson & Johnson’s Zytiga (abiraterone) in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy. Abiraterone … Continue reading →
Europe Approved Sutent for Rare Pancreatic Cancer
The European Commission has recently approved Sutent (sunitinib) as a medicine for treating patients with pancreatic neuroendocrine tumors (NET). The drug is now indicated to treat unresectable metastatic, well-differentiated pancreatic NET in adults with disease progression. The approval was based … Continue reading →
Good News for Women Who Have HER2-Positive, Herceptin-resistant, Metastatic Breast Cancer
A study published in the March issue of the Journal of Clinical Oncology indicated that breast cancer patients who have HER2/neu gene, but have failed Herceptin therapy, can now receive Tykerb, in addition to their Hercpetin, to improve their length of time … Continue reading →